Release Date: 14/09/15 11:08 Summary: First Patient in Phase II Trial Price Sensitive: Yes Download Document 87.58KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%